| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000047268 |
| Receipt No. | R000053895 |
| Scientific Title | Survey on dietary choices aimed at raising health awareness: a parallel group-to-group comparative study |
| Date of disclosure of the study information | 2022/03/23 |
| Last modified on | 2022/05/16 (Ver. 5) |
| Basic information | ||
| Public title | Survey on dietary choices aimed at raising health awareness: a parallel group-to-group comparative study | |
| Acronym | Survey on dietary choices aimed at raising health awareness: a parallel group-to-group comparative study | |
| Scientific Title | Survey on dietary choices aimed at raising health awareness: a parallel group-to-group comparative study | |
| Scientific Title:Acronym | Survey on dietary choices aimed at raising health awareness: a parallel group-to-group comparative study | |
| Region |
|
|
| Condition | ||
| Condition | healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We aimed to conduct an introduction test of the TLF label with the nutrition label affixed to the front of the food packaging and to verify its practicality when used for long periods in young people. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Compare dietary choices between the TLF-labeled and non-TLF-labeled groups for a week. |
| Key secondary outcomes | 1) Compare the increase and decrease in the number of people who are conscious of a healthy diet in the TLF label use group and the non-use group.
2) Evaluate which of the nutritional components that should be noted for overdose will become conscious in the TLF label use group and the non-use group. (Calorie, fat, saturated fatty acid, sugar, salt, etc.) 3) Evaluate whether there is a difference in how stress is felt between the TLF label use group and the non-use group. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intervention group: Select a meal once a day with the nutrition label (TLF label) when choosing a meal at dinner (for seven consecutive days) | |
| Interventions/Control_2 | Control group. Select a meal once a day at dinner without nutrition labeling (TLF labeling) (7 consecutive days) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Those who have received sufficient explanation about the purpose and contents of this research, have the ability to consent, volunteered voluntarily after fully understanding, and agreed to participate in writing. | |||
| Key exclusion criteria | Key exclusion criteria:
1) refuse to participate in the study; 2) Those who have dietary restrictions as a result of metabolic or endocrine disorders 3) People with eating disorders 4) Those who have anorexia 5) Those who have intentionally or unintentionally gained or lost weight by more than 5% in the past 3 months 6) are deemed ineligible by principal investigator for other reasons not listed above. |
|||
| Target sample size | 68 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hoshi University | ||||||
| Division name | Division of Applied Pharmaceutical Education and Research | ||||||
| Zip code | 142-8501 | ||||||
| Address | 2-4-41 Ebara, Shinagawa-ku, Tokyo | ||||||
| TEL | 03-5498-5760 | ||||||
| n-wakui@hoshi.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hoshi University | ||||||
| Division name | Division of Applied Pharmaceutical Education and Research | ||||||
| Zip code | 142-8501 | ||||||
| Address | 2-4-41 Ebara, Shinagawa-ku, Tokyo | ||||||
| TEL | 03-5498-5760 | ||||||
| Homepage URL | |||||||
| n-wakui@hoshi.ac.jp | |||||||
| Sponsor | |
| Institute | Hoshi University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hoshi University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Hoshi University Research Ethics Committee |
| Address | 142-8501, 2-4-41 Ebara, Shinagawa-ku, Tokyo |
| Tel | 03-3786-1011 |
| somu@hoshi.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053895 |